Cargando…

Epidemiology and Management of Antiretroviral-Associated Cardiovascular Disease

Risk and manifestations of cardiovascular disease (CVD) in patients infected with human immunodeficiency virus (HIV) will continue to evolve as improved treatments and life expectancy of these patients increases. Although initiation of antiretroviral (ARV) therapy has been shown to reduce this risk,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chastain, Daniel B, Henderson, Harold, Stover, Kayla R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391206/
https://www.ncbi.nlm.nih.gov/pubmed/25866592
http://dx.doi.org/10.2174/1874613601509010023
_version_ 1782365783233396736
author Chastain, Daniel B
Henderson, Harold
Stover, Kayla R
author_facet Chastain, Daniel B
Henderson, Harold
Stover, Kayla R
author_sort Chastain, Daniel B
collection PubMed
description Risk and manifestations of cardiovascular disease (CVD) in patients infected with human immunodeficiency virus (HIV) will continue to evolve as improved treatments and life expectancy of these patients increases. Although initiation of antiretroviral (ARV) therapy has been shown to reduce this risk, some ARV medications may induce metabolic abnormalities, further compounding the risk of CVD. In this patient population, both pharmacologic and nonpharmacologic strategies should be employed to treat and reduce further risk of CVD. This review summarizes epidemiology data of the risk factors and development of CVD in HIV and provides recommendations to manage CVD in HIV-infected patients.
format Online
Article
Text
id pubmed-4391206
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Bentham Open
record_format MEDLINE/PubMed
spelling pubmed-43912062015-04-10 Epidemiology and Management of Antiretroviral-Associated Cardiovascular Disease Chastain, Daniel B Henderson, Harold Stover, Kayla R Open AIDS J Article Risk and manifestations of cardiovascular disease (CVD) in patients infected with human immunodeficiency virus (HIV) will continue to evolve as improved treatments and life expectancy of these patients increases. Although initiation of antiretroviral (ARV) therapy has been shown to reduce this risk, some ARV medications may induce metabolic abnormalities, further compounding the risk of CVD. In this patient population, both pharmacologic and nonpharmacologic strategies should be employed to treat and reduce further risk of CVD. This review summarizes epidemiology data of the risk factors and development of CVD in HIV and provides recommendations to manage CVD in HIV-infected patients. Bentham Open 2015-03-31 /pmc/articles/PMC4391206/ /pubmed/25866592 http://dx.doi.org/10.2174/1874613601509010023 Text en © Chastain et al.; Licensee Bentham Open. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Chastain, Daniel B
Henderson, Harold
Stover, Kayla R
Epidemiology and Management of Antiretroviral-Associated Cardiovascular Disease
title Epidemiology and Management of Antiretroviral-Associated Cardiovascular Disease
title_full Epidemiology and Management of Antiretroviral-Associated Cardiovascular Disease
title_fullStr Epidemiology and Management of Antiretroviral-Associated Cardiovascular Disease
title_full_unstemmed Epidemiology and Management of Antiretroviral-Associated Cardiovascular Disease
title_short Epidemiology and Management of Antiretroviral-Associated Cardiovascular Disease
title_sort epidemiology and management of antiretroviral-associated cardiovascular disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391206/
https://www.ncbi.nlm.nih.gov/pubmed/25866592
http://dx.doi.org/10.2174/1874613601509010023
work_keys_str_mv AT chastaindanielb epidemiologyandmanagementofantiretroviralassociatedcardiovasculardisease
AT hendersonharold epidemiologyandmanagementofantiretroviralassociatedcardiovasculardisease
AT stoverkaylar epidemiologyandmanagementofantiretroviralassociatedcardiovasculardisease